Press Releases

THOUSAND OAKS, Calif.--(BUSINESS WIRE)-- Anthem Blue Cross (Anthem) today announced that the Company’s 2019 Medicare Advantage HMO plans, which will be offered in many counties throughout California, are rated 4.5 Stars by the Centers for Medicare & Medicaid Services (CMS), with five stars being the best rating. CMS’ Medicare Star Ratings gives health plans scores for the quality and performance

SEATTLE--(BUSINESS WIRE)-- Cancer Targeted Technology (CTT), a privately-held Seattle-based biotechnology company focusing on small molecules that bin

HOUSTON--(BUSINESS WIRE)-- Westlake Chemical Partners (NYSE: WLKP) will release its third quarter 2018 earnings prior to the market opening on Tuesday, November 6, 2018. The company will host a conference call at 12:00 p.m. Eastern Time (11:00 a.m. Central Time) on the same day to discuss the earnings release. To access the conference call, dial (855) 765-5686, or (234) 386-2848 for internatio

HOUSTON--(BUSINESS WIRE)-- Westlake Chemical Corporation (NYSE: WLK) will release its third quarter 2018 earnings prior to the market opening on Tuesday, November 6, 2018. The company will host a conference call at 11:00 a.m. Eastern Time (10:00 a.m. Central Time) on the same day to discuss the earnings release. To access the conference call, dial (855) 760-8160, or (704) 288-0624 for internat

EAST PROVIDENCE, R.I.--(BUSINESS WIRE)-- Nordson EFD, a Nordson company (NASDAQ:

MINNEAPOLIS--(BUSINESS WIRE)-- Humanetics Corporation (Humanetics) has been invited to present at the annual meeting of the American Society for Radiation Oncology (ASTRO) being held October 21st through the 24th in San Antonio, Texas. Dr. Michael Kurman, M.D., Chief Medical Officer for Humanetics, will be presenting an overview of the study design and providing an update on the status of

SAN DIEGO--(BUSINESS WIRE)-- Ablexis, LLC, a biopharmaceutical company focused on licensing its AlivaMab Mouse technology for antibody drug discovery, today announced a license

DALLAS--(BUSINESS WIRE)-- Zimperium is providing customers, media and the general public with a live webinar in which they will learn about the mobile threats hospitals and healthcare organizations are facing via a real-life example from a Zimperium customer. The webinar will review how these threats can gain access to sensitive patient and company data and how organizations can protect themselves and their pat

SANTA CLARA, Calif.--(BUSINESS WIRE)-- Aruba, a Hewlett Packard Enterprise company (NYSE: HPE), today announced that Liberty University, the largest university in Virginia, has completed a significant expansion of its Williams Stadium using Aruba wireless, security and network management solutions. The massive upgrade, which was completed in less than one year, is already delivering fast and reliable connectivi

AUSTIN, Texas--(BUSINESS WIRE)-- NI (Nasdaq: NATI), the provider of a software-defined platform that helps accelerate the development and performance of automated test and automated measurement systems, today announced the release of

TOKYO--(BUSINESS WIRE)-- Scientists at Morinaga Milk Industry Co., Ltd. (TOKYO:2264) have long theorized that Human-Residential Bifidob

GÖTTINGEN, Germany--(BUSINESS WIRE)-- Sartorius, a leading international partner of biopharmaceutical research and the industry, continued on the growth track, with double-digit gains in sales revenue and earnings. “In the first nine months of 2018, Sartorius achieved excellent organic growth,” said Dr. Joachim Kreuzburg, Chief Executive Officer. “This applies particularly

TOKYO--(BUSINESS WIRE)-- Mitsubishi Electric Corporation (TOKYO:6503) announced today that it has developed a unique dot forming technology that rea

COPENHAGEN, Denmark--(BUSINESS WIRE)-- MC2 Therapeutics A/S, a clinical-stage dermatology and eye care company, today announced topline results from the MC2-03-C1 Northern Lights Phase 2 trial evaluating the safety and efficacy of MC2-03 (PADciclo™) in moderate-to-severe dry eye (DED) patients. MC2-03 is an eye drop containing ciclosporin (CsA) formulated using MC2 Therapeutics’ proprietary PAD&trad

TEMPE, Ariz.--(BUSINESS WIRE)-- Amkor Technology, Inc. (Nasdaq: AMKR), a leading provider of semiconductor packaging and test services, today announced that it will issue its financial results for the third quarter 2018 after the close of trading on the NASDAQ Global Select Market on Monday, October 29, 2018. Amkor management will host a conference call to discuss the company's financial results at 5:00 p.m. Ea